Safety and Efficacy of Universal 4SCAR7U T Cell Therapy Targeting CD7-positive Hematological Malignancies

Study Summary

The purpose of this clinical trial is to assess the feasibility, safety and efficacy of universal CAR T cells based on 4SCAR7U design against CD7-positive hematological malignancies using CD7 specific universal CAR T cells. The study also aims to learn more about the function of CD7 targeting CAR T cells and their persistence in patients of hematological malignancies.

Interventions

Study Locations

Facility	City	State	Country
Shenzhen Geno-immune Medical Institute	Shenzhen	Guangdong	China

Official Trial Information

View on ClinicalTrials.gov